A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of Colonscopy

October 19, 2020 updated by: Renmin Hospital of Wuhan University

A Prospective, Randomized, Single-blind, 2 × 2 Factorial Design Single Center Study Evaluating the Polyp Detection and Quality Monitoring Function of EndoAngel in Improving the Quality of Colonoscopy

An artificial intelligence-based system, named EndoAngel,has been constructed previously,which has polyp detection and quality monitoring functions. This study aims to evaluate the two different functions of EndoAngle in improving adenoma detection rate.

Study Overview

Detailed Description

The detection and removal of precancerous polyps via colonoscopy can reduce the the risk of colon cancer. However, the detection rate of adenomatous polyps can vary significantly among endoscopists. EndoAngel is an artificial intelligence-based system,consisting of polyp detection and quality monitoring functions. The polyp detection function can remind endoscopists of the location of the polyp. The quality monitoring function can monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.This study aims to evaluate the two different functions of EndoAngle by 2 × 2 factorial design in improving adenoma detection rate and the quality of colonscopy .

Study Type

Interventional

Enrollment (Anticipated)

1090

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430060
        • Recruiting
        • Renmin Hospital of Wuhan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or female aged 18 years or above;
  2. Colonoscopy is needed to further characterize gastrointestinal diseases;
  3. Ability to read, understand and sign informed consent forms;
  4. The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.

Exclusion Criteria:

  1. Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials;
  2. Participate in a drug clinical trial and during the elution period of the trial or control drug;
  3. Drug or alcohol abuse or mental disorder in the last 5 years;
  4. Pregnant or lactating women;
  5. Patients with multiple polyp syndrome;
  6. Patients with a history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
  7. Patients with known perforation or colonic obstruction;
  8. Patients with a contraindication for biopsy;
  9. The researchers did not consider the subjects suitable for colonoscopy;
  10. The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Control group
Patients will receive colonoscopy without assistance of EndoAngel's any function.
Patient in this group will receive colonoscopy with assistance of EndoAngel's both functions.
Experimental: Polyp detection function group
Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection function.
Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.
Experimental: Quality monitoring function group
Patients will receive colonoscopy with the assistance of EndoAngel's quality monitoring function.
Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.
Experimental: Polyp detection plus quality monitoring functions group
Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection plus quality monitoring function.
Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.
Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate
Time Frame: 3 Months
The numerator is the number of cases of adenomas detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.
3 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Polyp detection rate
Time Frame: 3 months
The numerator is the number of cases of polyps detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.
3 months
The mean number of polyps per procedure
Time Frame: 3 months
The numerator is the total number of polyps detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
3 months
The mean number of adenomas per procedure
Time Frame: 3 months
The numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
3 months
Detection rate of large, small and diminutive polyps
Time Frame: 3 months
The numerator was the number of patients with large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
3 months
The mean number of large, small and diminutive polyps per procedure
Time Frame: 3 months
The numerator was the number of large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
3 months
Detection rate of large, small and diminutive adenomas
Time Frame: 3 months
The numerator was the number of patients with large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
3 months
The mean number of large, small and diminutive adenomas per procedure
Time Frame: 3 months
The numerator was the number of large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
3 months
Detection rate of adenoma in different sites
Time Frame: 3 months
The numerator is the number of cases of adenoma detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
3 months
The mean number of adenomas in different sites per procedure
Time Frame: 3 months
The numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
3 months
Time of colonoscopic insertion
Time Frame: 3 months
The duration of colonoscopic insertion from rectum to ileocecal valve or appendiceal opening
3 months
Time of colonoscopic withdrawal
Time Frame: 3 months
The duration of colonoscopic withdrawal from ileocecal valve or appendiceal opening to colonoscopy finished.
3 months
Cecal intubation rate
Time Frame: 3 months
The numerator is the number of cases of colonoscopy reaching ileocecal valve or appendiceal opening, and the denominator is the total number of colonoscopy cases.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Anticipated)

October 20, 2020

Study Completion (Anticipated)

October 30, 2020

Study Registration Dates

First Submitted

June 27, 2020

First Submitted That Met QC Criteria

June 27, 2020

First Posted (Actual)

July 1, 2020

Study Record Updates

Last Update Posted (Actual)

October 22, 2020

Last Update Submitted That Met QC Criteria

October 19, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adenoma

Clinical Trials on Colonoscopy without the assistance of EndoAngel's any function.

Subscribe